Moderna, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2016 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Moderna, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Moderna, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was -$146M, a 192% decline year-over-year.
- Moderna, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $901K.
- Moderna, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$578M.
- Moderna, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$296M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)